Tonbo Imaging India IPO Analysis: Should You Apply? GMP, Review & Details

Tonbo Imaging India is a MAINBOARD IPO in the Aerospace & Defense sector. The issue price band is ₹665.0–₹700.0 per share. Issue size is ₹852.18 crore. Current GMP is +64.29% over the issue price (unofficial, subject to change).

Tonbo Imaging India IPO — Key Details

Company Overview

Tonbo Imaging India Limited, incorporated in December 2003, is a global defence electronics original equipment manufacturer (OEM). The company specializes in the design, development, and manufacturing of advanced electro-optic, infrared (EO/IR), communication, guidance, and surveillance systems tailored for defence and security applications. Its product range includes thermal imaging systems, weapon sights, missile seekers, and targeting systems, among others. Tonbo serves defence and security organizations across 24 countries, boasting over 28,000 field-deployed systems. The company is recognized as India's largest manufacturer and exporter of thermal imaging systems, leveraging proprietary technologies and a strong in-house R&D framework.

Financial Performance

Total income was ₹431.90 Cr in FY24, slightly increasing to ₹474.39 Cr by FY25. However, it then decreased to ₹369.94 Cr in FY26, followed by a decline to ₹37.32 Cr by June 30, 2026. This last figure represents a 9-month period, not a full year, so isn't directly comparable. Profit after tax was ₹68.54 Cr in FY24, rising to ₹72.76 Cr in FY25. This was followed by a significant drop to ₹50.88 Cr in FY26 and a further decline to -₹17.74 Cr by June 30, 2026. Again, this last figure is from a 9-month period, making it not directly comparable to the prior full fiscal years.

Objects of the Issue

The funds raised through this IPO will be utilized for various purposes, including working capital requirements and general corporate purposes.

Strengths & Weaknesses

Strengths

Tonbo Imaging stands out as a leading defence electronics OEM with proprietary technologies in electro-optics and thermal imaging. The company benefits from strong in-house R&D capabilities, a diverse product portfolio, and a global presence with ITAR-free export capabilities. Its asset-light, innovation-driven business model supports healthy financial performance.

Weaknesses

The company has recently reported a decline in total income and a negative profit after tax in the latest period, which may raise concerns about its financial stability.

Risk Factors

Investors should consider potential risks such as market volatility, reliance on government contracts, and competition within the defence sector. Additionally, the recent decline in financial performance could be a concern for potential investors.

Understanding Grey Market Premium (GMP)

The grey market premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests that investors are optimistic about the stock's performance on listing day.

Subscription Status

The IPO has seen significant interest, with the overall subscription at 132.81 times as of October 19, 2026. The institutional category (QIB) was subscribed 293.56 times, while retail investors (RII) saw a subscription of 31.11 times.

IPO Timeline

The IPO opens on October 15, 2026, and closes on October 19, 2026. Allotment of shares will be announced on October 21, 2026, with the listing date set for October 23, 2026.

Should You Apply for Tonbo Imaging India IPO?

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their risk tolerance and investment strategy. It's essential to consider the company's financial health and market position before making any investment decisions.

Those who prefer stable investments with consistent financial performance may want to avoid this IPO, especially given the recent financial declines and uncertainties in the defence sector.

This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.

Listing Day Risks

Listing-day gains can be unpredictable and depend on various factors, including market conditions and investor sentiment. While a positive GMP may indicate potential gains, there is no guarantee that the stock will perform well once listed.

Trending Searches

Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.